SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...
The WEB device has proven clinical data, supported by seven global Good Clinical Practice (GCP) studies 2-8 and over 200 peer-reviewed publications. Over the past 15 years, this revolutionary ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of incomplete wall apposition and braid deformation, which could lead to stroke or ...
LONDON--(BUSINESS WIRE)--The global vascular embolization devices market is expected to grow by USD 1 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Boston Scientific announced it received FDA 510(k) ...
Medtronic is recalling the Pipeline Flex embolization device and Pipeline Flex embolization device with shield technology because the delivery system's wire and tubes could fracture and break off when ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Okami Medical has raised $45 million to commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results